logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrew Wardley

University of London
H指数:53
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer

通过坚持辅助内分泌治疗改善早期乳腺癌女性的结局（SWEET）：一项实用性随机对照试验的研究方案，旨在通过以患者为中心的干预措施提高早期乳腺癌患者对内分泌治疗的依从性。

TRIALS
IF2
2025-11-261
OAAI
Mcgeagh, Lucy; Walker, Alice; Hiller, Louise; Dunn, Janet; Wells, Mary; Donnelly, Peter; Wardley, Andrew; Wolstenholme, Jane; Horne, Robert; Stewart, Sarah-Jane; Brett, Jo; Cahir, Caitriona; Fenlon, Deborah; Rose, Jan; Turner, Lesley; Hughes, Lyndsay; Todd, Adam; Nicholson, Brian; Mawson, Phil; Norris, Ruth; Thompson, Sue; Dakin, Helen; Barrows, Raegan; Kum, Sally; Turner, Mark; Rehman, Farah; Cain, Henry; Watson, Eila; Sharp, Linda; King, Alex; Harmer, Victoria; Levitt, Nicky; Mann, Anna; Mccowan, Colin; Moon, Zoe; Porteous, Mia; Smith, Samuel G.
The prognostic and predictive impact of circulating tumour DNA (ctDNA) dynamics in patients with metastatic Triple Negative Breast Cancer (TNBC) on olaparib based therapy: Results from Cohort E of the PlasmaMATCH trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Browne, Iseult; Pascual, Javier; Cutts, Rosalind; Kingston, Belinda; Hrebien, Sarah; Kilburn, Lucy; Pearson, Alex; Moretti, Laura; Wardley, Andrew; Macpherson, Iain; Baird, Richard; Roylance, Rebecca; Faull, Iris; Banks, Kimberly C.; Garcia-Murillas, Isaac; Bliss, Judith; Ring, Alistair; Turner, Nicholas
Tracking triple negative breast cancer (TNBC) evolution in the molecular residual disease (MRD) setting in the c-TRAK TN clinical trial
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Coakley, Maria; Cutts, Rosalind J.; Sritharan, Prithika; Hrebien, Sarah; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Villacampa, Guillermo; Rojas, Patricia; Emmett, Warren; Pipinikas, Christodoulos; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Bliss, Judith M.; Garcia-Murillas, Isaac; Turner, Nicholas C.
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer
CLINICAL CANCER RESEARCH
IF10.2
2023-12-110
OAAI
Coakley, Maria; Villacampa, Guillermo; Sritharan, Prithika; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Pipinikas, Christodoulos; Rojas, Patricia; Emmett, Warren; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Palmieri, Carlo; Winter, Matthew; Cutts, Rosalind J.; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas C.
Comparison of a personalized sequencing assay and digital PCR for circulating tumor DNA based Molecular Residual Disease detection in early-stage triple negative breast cancer in the cTRAK-TN trial
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Coakley, Maria; Sritharan, Prithika; Villacampa, Guillermo; Swift, Claire; Dunne, Kathryn; Kilburn, Lucy; Goddard, Katie; Rojas, Patricia; Joad, Andy; Emmett, Warren; Knape, Charlene; Howarth, Karen; Hall, Peter S.; Harper-Wynne, Catherine; Hickish, Tamas; Macpherson, Iain; Okines, Alicia F.; Wardley, Andrew M.; Wheatley, Duncan; Waters, Simon; Cutts, Rosalind; Garcia-Murillas, Isaac; Bliss, Judith; Turner, Nicholas
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
ANNALS OF ONCOLOGY
IF65.4
2023-02-0164
OAAI
Turner, N. C.; Swift, C.; Jenkins, B.; Kilburn, L.; Coakley, M.; Beaney, M.; Fox, L.; Goddard, K.; Garcia-Murillas, I.; Proszek, P.; Hall, P.; Harper-Wynne, C.; Hickish, T.; Kernaghan, S.; Macpherson, I. R.; Okines, A. F. C.; Palmieri, C.; Perry, S.; Randle, K.; Snowdon, C.; Stobart, H.; Wardley, A. M.; Wheatley, D.; Waters, S.; Winter, M. C.; Hubank, M.; Allen, S. D.; Bliss, J. M.
Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer
CANCER RESEARCH
IF16.6
2022-02-1510
PRE
Turner, Nicholas; Swift, Claire; Jenkins, Ben; Kilburn, Lucy; Coakley, Maria; Beaney, Matthew; Fox, Lisa; Goddard, Katie; Garcia-Murillas, Isaac; Hall, Peter; Harper-Wynne, Catherine; Hickish, Tamas; Kernaghan, Sarah; Macpherson, Iain; Okines, Alicia; Palmieri, Carlo; Perry, Sophie; Randle, Katrina; Snowdon, Claire; Stobart, Hilary; Wardley, Andrew; Wheatley, Duncan; Waters, Simon; Winter, Matthew; Bliss, Judith
The HER2-RADiCAL study (Response ADaptive CAre pLan) - Tailoring treatment for HER2 positive early breast cancer
CANCER RESEARCH
IF16.6
2022-02-153
PRE
Macpherson, Iain; McIntosh, Stuart; Kilburn, Lucy; Tovey, Holly; Kernaghan, Sarah; Goddard, Katie; Bhattacharya, Indrani; Boyd, Clinton; Coles, Charlotte; Kirwan, Cliona; Mackenzie, Mairead; O'Brien, Ciara; Ring, Alistair; Snowdon, Claire; Stobart, Hilary; Wheatley, Duncan; Wardley, Andrew; Shaaban, Abeer; Hall, Peter; Cameron, David; Bliss, Judith
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

IMpassion131的主要结果，一项双盲，安慰剂对照，随机III期临床试验，一线紫杉醇加或不加阿特珠单抗治疗不可切除的局部晚期/转移性三阴性乳腺癌

ANNALS OF ONCOLOGY
IF65.4
2021-08-01433
OAAI
Miles, D.; Gligorov, J.; Andre, F.; Cameron, D.; Schneeweiss, A.; Barrios, C.; Xu, B.; Wardley, A.; Kaen, D.; Andrade, L.; Semiglazov, V; Reinisch, M.; Patel, S.; Patre, M.; Morales, L.; Patel, S. L.; Kaul, M.; Barata, T.; O'Shaughnessy, J.
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial)

在曲妥珠单抗和卡培他滨的基础上加用特卡替尼或安慰剂治疗的人表皮生长因子受体2阳性转移性乳腺癌患者的生活质量保护 (HER2CLIMB试验)

EUROPEAN JOURNAL OF CANCER
IF7.1
2021-08-0111
OAAI
Mueller, Volkmar; Wardley, Andrew; Paplomata, Elisavet; Hamilton, Erika; Zelnak, Amelia; Fehrenbacher, Louis; Jakobsen, Erik; Curtit, Elsa; Boyle, Frances; Brix, Eva Harder; Brenner, Andrew; Crouzet, Laurence; Ferrario, Cristiano; Munoz-Mateu, Montserrat; Arkenau, Hendrik-Tobias; Iqbal, Nayyer; Aithal, Sramila; Block, Margaret; Cold, Soeren; Cancel, Mathilde; Hahn, Olwen; Poosarla, Teja; Stringer-Reasor, Erica; Colleoni, Marco; Cameron, David; Curigliano, Giuseppe; Siadak, Muriel; DeBusk, Kendra; Ramos, Jorge; Feng, Wentao; Gelmon, Karen
Genomic profile of advanced breast cancer in circulating tumor DNA (vol 12, 2423, 2021)
NATURE COMMUNICATIONS
IF15.7
2021-07-161
OAAI
Kingston, Belinda; Cutts, Rosalind J.; Bye, Hannah; Beaney, Matthew; Walsh-Crestani, Giselle; Hrebien, Sarah; Swift, Claire; Kilburn, Lucy S.; Kernaghan, Sarah; Moretti, Laura; Wilkinson, Katie; Wardley, Andrew M.; Macpherson, Iain R.; Baird, Richard D.; Roylance, Rebecca; Reis-Filho, Jorge S.; Hubank, Michael; Faull, Iris; Banks, Kimberly C.; Lanman, Richard B.; Garcia-Murillas, Isaac; Bliss, Judith M.; Ring, Alistair; Turner, Nicholas C.
Genomic profile of advanced breast cancer in circulating tumour DNA
NATURE COMMUNICATIONS
IF15.7
2021-04-2371
OAAI
Kingston, Belinda; Cutts, Rosalind J.; Bye, Hannah; Beaney, Matthew; Walsh-Crestani, Giselle; Hrebien, Sarah; Swift, Claire; Kilburn, Lucy S.; Kernaghan, Sarah; Moretti, Laura; Wilkinson, Katie; Wardley, Andrew M.; Macpherson, Iain R.; Baird, Richard D.; Roylance, Rebecca; Reis-Filho, Jorge S.; Hubank, Michael; Faull, Iris; Banks, Kimberly C.; Lanman, Richard B.; Garcia-Murillas, Isaac; Bliss, Judith M.; Ring, Alistair; Turner, Nicholas C.
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+and androgen receptor-positive metastatic or locally advanced breast cancer

恩扎鲁胺联合曲妥珠单抗治疗HER2和雄激素受体阳性转移性或局部晚期乳腺癌的疗效和安全性

BREAST CANCER RESEARCH AND TREATMENT
IF3
2021-02-1623
OAAI
Wardley, Andrew; Cortes, Javier; Provencher, Louise; Miller, Kathy; Chien, A. Jo; Rugo, Hope S.; Steinberg, Joyce; Sugg, Jennifer; Tudor, Iulia C.; Huizing, Manon; Young, Robyn; Abramson, Vandana; Bose, Ron; Hart, Lowell; Chan, Stephen; Cameron, David; Wright, Gail S.; Graas, Marie-Pascale; Neven, Patrick; Rocca, Andrea; Russo, Stefania; Krop, Ian E.

研究方向

暂未获取到该数据
J
Judith M. Bliss
H 指数:90论文数:805被引数:3.8万
D
David Cameron
H 指数:108论文数:1,037被引数:6.6万
L
Lucy Kilburn
H 指数:31论文数:327被引数:7,262
N
Nicholas C. Turner
H 指数:92论文数:1,157被引数:4.5万
I
Iain R. Macpherson
H 指数:38论文数:295被引数:7,093
R
Rebecca Roylance
H 指数:42论文数:242被引数:9,996
S
Sarah Kernaghan
H 指数:12论文数:99被引数:1,943
R
Richard D. Baird
H 指数:41论文数:369被引数:1.1万
H
Helena Earl
H 指数:61论文数:363被引数:1.6万
A
Alistair Ring
H 指数:36论文数:307被引数:5,663